A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR�(long-acting repeatable octreotide) in the primary therapy of patients with acromegaly-Reference-Cited by-同舟云学术

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR�(long-acting repeatable octreotide) in the primary therapy of patients with acromegaly

Published:2007-06 Issue:6 Volume:66 Page:859-868
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Mercado Moises,Borges Fatima,Bouterfa Hakim,Chang Tien-Chun,Chervin Alberto,Farrall Andrew J.,Patocs Attila,Petersenn Stephan,Podoba Jan,Safari Mitra,Wardlaw Joanna,

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2007.02825.x/fullpdf

Reference29 articles.

1. Clinical Manifestations of Acromegaly

2. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly

3. Determinants of clinical outcome and survival in acromegaly

4. Factors Influencing Mortality in Acromegaly

5. Guidelines for Acromegaly Management

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Current role of pasireotide in the treatment of acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults;Cochrane Database of Systematic Reviews;2024-02-06

4. Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly;Journal of Neurosurgery;2023-10-01

5. The heptapeptide somatostatin analogue TT-232 exerts analgesic and anti-inflammatory actions via SST4 receptor activation: In silico, in vitro and in vivo evidence in mice;Biochemical Pharmacology;2023-03